Abstract
Purpose To evaluate the efficacy of albendazole in the management of orbital myocysticercosis.
Method Twenty-one consecutive patients diagnosed as having orbital myocysticercosis by ultrasonography, supported by computed tomography (CD/magnetic resonance imaging (MRI), were included in the study. All patients received oral albendazole at a dosage of 30 mg/kg for 15 days with a low-dose steroid cover (5-10 mg per day). The patients were followed on day 2, at 2 weeks, 1 month, 3 months, 6 months and 9 months, and finally at 1 year. Orbital sonography was performed at 2 weeks, 3 months, 6 months, 9 months and 1 year. CT scan was performed at 6 months and 1 year.
Results Orbital sonography revealed a well-defined cystic lesion with clear contents and a hyperechoic area suggestive of a scolex in all the patients. CT or MRI provided additional supportive evidence. The size of the cysts measured before treatment ranged from 6.2 to 13.4 mm (mean 11.4 mm). Medial rectus was involved in 10 cases, superior rectus in 7 cases and lateral rectus in 4 cases. Serial ultrasonography revealed a gradual reduction in the cyst size in 20 patients. A mild obscuration of the cyst wall, followed by collapse of the cyst cavity and obscuration of the scolex, were progressively seen as the cyst reduced in size. Complete resolution of the cyst was seen in all cases at 6 months. A CT scan performed at 1 year supported the ultrasonographic findings. No systemic side effects were noted.
Conclusion Oral albendazole appears to be highly efficacious in the management of orbital myocysticercosis.
Similar content being viewed by others
Article PDF
References
Malik SRK, Gupta AK, Chaudhary S . Ocular cysticercosis. Am J Ophthalmol 1968;66:1168–71.
Shields J . Diagnosis and management of orbital tumours. Philadelphia: WB Saunders, 1989:117–9.
Ruterman J . Diseases of the orbit. Philadelphia: JB Lippincott, 1988:159–60.
Chandra Shekar G, Lemke BN . Orbital cysticercosis. Ophthalmology 1997;104:1599–604.
Sotelo J, Escobedo F, Penagos P . Albendazole vs praziquantel for therapy of neurocysticercosis. Arch Neurol 1988;45:532–4.
Escobedo F, Penagos P, Roperriguez J . Albendazole therapy for neurocysticercosis. Arch Neurol 1986;43:353–6.
Sihota R, Hanowar SG . Oral albendazole in management of extraocular cysticercosis. Br J Ophthalmol 1994;78:621–3.
Zenteno MA, Del Brutto OH, Honag B . Neurocysticercosis en pays d'endemic (Méxique internet de 1'IRM). Presented at the annual meeting of the Société Française de Neuroradiologie, Paris, France, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Puri, P., Grover, A. Medical management of orbital myocysticercosis: a pilot study. Eye 12, 795–799 (1998). https://doi.org/10.1038/eye.1998.206
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.206
Keywords
This article is cited by
-
Simultaneous Intraocular and Bilateral Extraocular Muscle Involvement in a Case of Disseminated Cysticercosis
International Ophthalmology (2006)
-
Uniocular ptosis due to cysticercosis of extraocular muscle
The Indian Journal of Pediatrics (2004)